Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$229.03 USD
+1.22 (0.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $228.97 -0.06 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/9/24 |
---|---|
Current Quarter | 2.05 |
EPS Last Quarter | 2.46 |
Last EPS Surprise | 2.93% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 11.01 |
Next Year | 12.37 |
EPS (TTM) | 10.65 |
P/E (F1) | 20.81 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 997.24M | 1.04B | 4.22B | 4.54B |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 1.00B | 1.05B | 4.24B | 4.59B |
Low Estimate | 995.59M | 1.03B | 4.20B | 4.45B |
Year ago Sales | 1.03B | 1.06B | 4.13B | 4.22B |
Year over Year Growth Est. | -3.12% | -1.92% | 2.13% | 7.71% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.05 | 2.62 | 11.01 | 12.37 |
# of Estimates | 7 | 5 | 9 | 9 |
Most Recent Consensus | 2.05 | 2.61 | 10.88 | 12.34 |
High Estimate | 2.11 | 2.67 | 11.19 | 12.88 |
Low Estimate | 2.00 | 2.56 | 10.88 | 12.01 |
Year ago EPS | 2.78 | 2.69 | 10.67 | 11.01 |
Year over Year Growth Est. | -26.26% | -2.60% | 3.19% | 12.40% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.05 | 2.62 | 11.01 | 12.37 |
7 Days Ago | 2.05 | 2.62 | 11.01 | 12.37 |
30 Days Ago | 2.05 | 2.62 | 11.01 | 12.37 |
60 Days Ago | 2.14 | 2.62 | 10.99 | 12.43 |
90 Days Ago | 2.52 | 2.67 | 10.94 | 12.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.05 | 2.62 | 11.01 | 12.37 |
Zacks Consensus Estimate | 2.05 | 2.62 | 11.01 | 12.37 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.46 | 2.72 | 2.69 | 2.78 | NA |
Estimate | 2.39 | 2.35 | 2.63 | 2.59 | NA |
Difference | 0.07 | 0.37 | 0.06 | 0.19 | 0.17 |
Surprise | 2.93% | 15.74% | 2.28% | 7.34% | 7.07% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more